文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

聚合物纳米粒用于药物和小干扰 RNA 的递送来治疗不同表型的癌症。

Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes.

机构信息

Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Palo Alto, CA, USA.

出版信息

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Jan-Feb;6(1):40-60. doi: 10.1002/wnan.1242. Epub 2013 Aug 31.


DOI:10.1002/wnan.1242
PMID:23996830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3865230/
Abstract

Advances in nanotechnology have provided powerful and efficient tools in the development of cancer diagnosis and therapy. There are numerous nanocarriers that are currently approved for clinical use in cancer therapy. In recent years, biodegradable polymer nanoparticles have attracted a considerable attention for their ability to function as a possible carrier for target-specific delivery of various drugs, genes, proteins, peptides, vaccines, and other biomolecules in humans without much toxicity. This review will specifically focus on the recent advances in polymer-based nanocarriers for various drugs and small silencing RNA's loading and delivery to treat different types of cancer.

摘要

纳米技术的进步为癌症的诊断和治疗提供了强大而有效的工具。目前有许多纳米载体已被批准用于癌症治疗的临床应用。近年来,可生物降解的聚合物纳米粒子因其能够作为各种药物、基因、蛋白质、肽、疫苗和其他生物分子的靶向递释载体而受到广泛关注,而其毒性则较低。本综述将特别关注用于各种药物和小干扰 RNA 负载和递送至治疗不同类型癌症的基于聚合物的纳米载体的最新进展。

相似文献

[1]
Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013-8-31

[2]
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

Eur J Pharm Biopharm. 2015-6

[3]
Recent advances in siRNA delivery for cancer therapy using smart nanocarriers.

Drug Discov Today. 2018-1-31

[4]
Theranostic Nanoparticles for RNA-Based Cancer Treatment.

Acc Chem Res. 2019-5-28

[5]
Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.

World J Gastroenterol. 2015-11-14

[6]
Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.

Curr Top Med Chem. 2019

[7]
A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy.

J Mater Chem B. 2018-12-20

[8]
Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.

Acc Chem Res. 2018-10-15

[9]
Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.

Acc Chem Res. 2011-7-26

[10]
Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy.

Colloids Surf B Biointerfaces. 2020-12

引用本文的文献

[1]
Membrane-modified lipid nanoparticles for RNA delivery.

Mol Ther Methods Clin Dev. 2025-6-9

[2]
Gold Nanoparticles Synthesized with Triple-Negative Breast Cancer Cell Lysate Enhance Antitumoral Immunity: A Novel Synthesis Method.

Pharmaceuticals (Basel). 2025-2-26

[3]
The Plethora of RNA-Protein Interactions Model a Basis for RNA Therapies.

Genes (Basel). 2025-1-2

[4]
RNA Structure: Past, Future, and Gene Therapy Applications.

Int J Mol Sci. 2024-12-26

[5]
Gemcitabine and synthesized silver nanoparticles impact on chemically induced hepatocellular carcinoma in male rats.

Int J Immunopathol Pharmacol. 2024

[6]
Challenges and advances of the stability of mRNA delivery therapeutics.

Nucl Acid Insights. 2024-3

[7]
The Multifaceted Role of miR-21 in Pancreatic Cancers.

Cells. 2024-5-30

[8]
Chitosan/Alginate-Based Nanoparticles for Antibacterial Agents Delivery.

Int J Nanomedicine. 2024

[9]
Nanotechnology Integrated Innovative Drug Delivery and Therapy for Cancer.

Curr Pharm Biotechnol. 2024-4-22

[10]
Fabrication of Nanocrystals for Enhanced Distribution of a Fatty Acid Synthase Inhibitor (Orlistat) as a Promising Method to Relieve Solid Ehrlich Carcinoma-Induced Hepatic Damage in Mice.

Pharmaceuticals (Basel). 2024-1-10

本文引用的文献

[1]
Design of Nanoparticles as Drug Carriers for Cancer Therapy.

Cancer Genomics Proteomics. 2006

[2]
Toxicology and clinical potential of nanoparticles.

Nano Today. 2011-12

[3]
Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.

World J Gastroenterol. 2012-11-14

[4]
Targeted delivery of biodegradable nanoparticles with ultrasound-targeted microbubble destruction-mediated hVEGF-siRNA transfection in human PC-3 cells in vitro.

Int J Mol Med. 2012-11-8

[5]
5-Fluorouracil nanoparticles inhibit hepatocellular carcinoma via activation of the p53 pathway in the orthotopic transplant mouse model.

PLoS One. 2012-10-15

[6]
Toxicological aspects for nanomaterial in humans.

Methods Mol Biol. 2013

[7]
Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma.

Life Sci. 2012-10-5

[8]
Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats.

Colloids Surf B Biointerfaces. 2012-6-28

[9]
Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells.

BMC Cancer. 2012-9-22

[10]
Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.

Appl Biochem Biotechnol. 2012-9-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索